Danaher (NYSE:DHR) Receives Hold Rating from Royal Bank of Canada
Danaher (NYSE:DHR)‘s stock had its “hold” rating reaffirmed by analysts at Royal Bank of Canada in a report issued on Thursday, January 4th. They currently have a $96.00 target price on the conglomerate’s stock. Royal Bank of Canada’s target price would indicate a potential downside of 7.42% from the stock’s current price.
A number of other brokerages also recently issued reports on DHR. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Credit Suisse Group reiterated a “hold” rating and set a $99.00 price objective on shares of Danaher in a research note on Tuesday, December 19th. Robert W. Baird reiterated a “buy” rating and set a $99.00 price objective on shares of Danaher in a research note on Friday, December 15th. Evercore ISI began coverage on shares of Danaher in a research note on Wednesday, January 3rd. They set an “outperform” rating on the stock. Finally, Citigroup increased their price objective on shares of Danaher to $107.00 and gave the stock a “buy” rating in a research note on Friday, December 15th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. Danaher has an average rating of “Buy” and an average price target of $96.10.
Shares of Danaher (NYSE:DHR) opened at $103.69 on Thursday. The stock has a market cap of $72,130.00, a PE ratio of 30.86, a price-to-earnings-growth ratio of 2.25 and a beta of 1.03. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. Danaher has a one year low of $78.97 and a one year high of $104.22.
Hedge funds and other institutional investors have recently modified their holdings of the stock. GQG Partners LLC bought a new position in Danaher during the 2nd quarter worth approximately $101,000. Zions Bancorporation raised its holdings in Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after purchasing an additional 667 shares during the last quarter. Patten Group Inc. raised its holdings in Danaher by 262.3% during the 3rd quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 3,497 shares during the last quarter. First Personal Financial Services raised its holdings in Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 691 shares during the last quarter. Finally, Monetary Management Group Inc. raised its holdings in Danaher by 10.7% during the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after purchasing an additional 150 shares during the last quarter. Institutional investors and hedge funds own 76.16% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Danaher (NYSE:DHR) Receives Hold Rating from Royal Bank of Canada” was posted by Marea Informative and is the property of of Marea Informative. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.mareainformativa.com/2018/01/30/danaher-dhr-earns-hold-rating-from-royal-bank-of-canada-updated-updated-updated.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.